CRISPR-Cas9, the new kid on the block of fungal molecular biology

Medical Mycology

Volumn 55, Issue 1, 2017, Pages 16-23

  Krappmann, Sven ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Aspergillus; CRISPR Cas; Molecular biology

Indexed keywords

RNA; SINGLE GUIDING RNA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ASPERGILLUS FUMIGATUS; CONFERENCE PAPER; CRISPR CAS SYSTEM; FUNGAL GENOME; FUNGUS; GENE TARGETING; GENETIC POLYMORPHISM; MOLECULAR BIOLOGY; MUTAGENESIS; NONHUMAN; GENETICS; MICROBIAL GENETICS; PHYSIOLOGY; PROCEDURES; TRENDS;

ASPERGILLUS FUMIGATUS; GENE TARGETING; GENETICS, MICROBIAL; MUTAGENESIS;

EID: 85015959907     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myw097     Document Type: Conference Paper

References (33)

1. Brown GD, Denning DW, Gow NA et al. Hidden killers: human fungal infections. Sci. Transl. Med. 2012; 4: 165rv13.
2. Denning DW, Bromley MJ. Infectious Disease: how to bolster the antifungal pipeline. Science. 2015; 347: 1414-1416.
3. Barrangou R, Fremaux C, Deveau H et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007; 315: 1709-1712.
4. Ishino Y, Shinagawa H, Makino K et al. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J. Bacteriol. 1987; 169: 5429-5433.
5. Bolotin A, Quinquis B, Sorokin A et al. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology. 2005; 151: 2551-2561.
6. Mojica FJ, Diez-Villasenor C, Garcia-Martinez J et al. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J. Mol. Evol. 2005; 60: 174-182.
7. Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology. 2005; 151: 653-663.
8. Makarova KS, Grishin NV, Shabalina SA et al. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol. Direct. 2006; 1: 7.
9. Makarova KS, Aravind L, Wolf YI et al. Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems. Biol. Direct. 2011; 6: 38.
10. Jinek M, Chylinski K, Fonfara I et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012; 337: 816-821.
11. Doudna JA, Charpentier E. Genome editing: the new frontier of genome engineering with CRISPR-Cas9. Science. 2014; 346: 1258096.
12. Bondy-Denomy J, Davidson AR. To acquire or resist: the complex biological effects of CRISPR-Cas systems. Trends Microbiol. 2014; 22: 218-225.
13. Chylinski K, Makarova KS, Charpentier E et al. Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res. 2014; 42: 6091-6105.
14. Gasiunas G, Barrangou R, Horvath P et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U. S. A. 2012; 109: E2579-2586.
15. Mali P, Esvelt KM, Church GM. Cas9 as a versatile tool for engineering biology. Nat. Methods. 2013; 10: 957-963.
16. Jinek M, Jiang F, Taylor DW et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science. 2014; 343: 1247997.
17. van der Oost J, Westra ER, Jackson RN et al. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol. 2014; 12: 479-492.
18. Matsu-ura T, BaekM, Kwon J et al. Efficient gene editing in Neurospora crassa with CRISPR technology. Fungal Biol Biotechnol. 2015; 2: 4-10.
19. Nødvig CS, Nielsen JB, Kogle ME et al. A CRISPR-Cas9 system for genetic engineering of filamentous fungi. PLoS One. 2015; 10: e0133085.
20. Liu R, Chen L, Jiang Y et al. Efficient genome editing in filamentous fungus Trichoderma reesei using the CRISPR/Cas9 system. Cell Discovery. 2015; 1: 15007.
21. Schuster M, Schweizer G, Reissmann S et al. Genome editing in Ustilago maydis using the CRISPR-Cas system. Fungal. Genet. Biol. 2016; 89: 3-9.
22. Arazoe T, Miyoshi K, Yamato T et al. Tailor-made CRISPR/Cas system for highly efficient targeted gene replacement in the rice blast fungus. Biotechnol. Bioeng. 2015; 112: 2543-2549.
23. Vyas VK, Barrasa MI, Fink GR. A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families. Sci Adv. 2015; 1: e1500248.
24. Fuller KK, Chen S, Loros JJ et al. Development of the CRISPR/Cas9 system for targeted gene disruption in Aspergillus fumigatus. Eukaryot. Cell. 2015; 14: 1073-1080.
25. Zhang C, Meng X, Wei X et al. Highly efficient CRISPR mutagenesis by microhomology-mediated end joining in Aspergillus fumigatus. Fungal. Genet. Biol. 2016; 86: 47-57.
26. Brakhage AA, Langfelder K. Menacing mould: the molecular biology of Aspergillus fumigatus. Annu. Rev. Microbiol. 2002; 56: 433-455.
27. Krappmann S. Tools to study molecular mechanisms of Aspergillus pathogenicity. Trends Microbiol. 2006; 14: 356-364.
28. Hansen BG, Salomonsen B, Nielsen MT et al. Versatile enzyme expression and characterization system for Aspergillus nidulans, with the Penicillium brevicompactum polyketide synthase gene from the mycophenolic acid gene cluster as a test case. Appl. Environ. Microbiol. 2011; 77: 3044-3051.
29. Katayama T, Tanaka Y, Okabe T et al. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae. Biotechnol. Lett. 2016; 38: 637-642.
30. Ceasar SA, Rajan V, Prykhozhij SV et al. Insert, remove or replace: a highly advanced genome editing system using CRISPR/Cas9. Biochim. Biophys. Acta. 2016; 1863: 2333-2344.
31. Krappmann S. Gene targeting in filamentous fungi: the benefits of impaired repair. Fungal Biol. Rev. 2007; 21: 25-29.
32. Miles LA, Garippa RJ, Poirier JT. Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens. FEBS J. 2016; 283: 3170-3180.
33. Tschaharganeh DF, Lowe SW, Garippa RJ et al. Using CRISPR/Cas to study gene function and model disease in vivo. FEBS J. 2016; 283: 3194-3203.